Malaria Vaccine for Children in Mali
NCT00740090
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
200
Enrollment
NIH
Sponsor class
Conditions
Malaria
Malaria Infection
Interventions
DRUG:
AMA1-C1/Alhydrogel plus CPG 7909
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)